Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_sep96_decls20_0002.txt
Subject: MOA ON INVESTIGATIONAL USE OF DRUGS ANTIBIOTICS
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: MOU BETWEEN THE FOOD AND DRUG ADMINISTRATION AND DOD
Document Number: 1
Folder SEQ #: 133
2 DOD/FDA MOU-87
dev.ices at 21 CFR 812 and 813; for protection of human
subjects at 21 CFR 50; and for institutional review boards at
21 CFR 56. These regulations establish the procedure and
prescribe the necessary forms to be filed in order to exempt
drugs and devices to be used for investigational purposes
from, inter alia, the approval procedures of the Federal
Food, Drug, and Cosmetic Act and the biologic licensing
provisions of the Public Health Service Act.
Pursuant to Title 5, Section 301, of the United States Code,
DOD regulations on protection of human subjects in DOD-
supported research in 32 CFR Part 219 and DOD Directive
3216.2 generally adopt the system of Institutional Review
Boards (IRBS) established under 21 CFR 56. However, the
functions of research protocol review and approval are
separate in the Department of Defense. The function of
protocol review remains with the IRB which recommends
approval. The function of approval is held by the commander
to whom the review committee reports. in addition, the
Surgeon General of each Service may require that the final
review and approval for use of investigational drugs,
biologics, or medical devices, remain within his or her
office. The Surgeons General have the authority to-delegate
this final review and approval authority to a "Headquarters
Review Board" (HRB), or the medical department component
holding the IND or IDE. In no case can an approving
authority or HRB give final approval to a protocol which has
been disapproved by a local IRB, nor can an approving
authority or HRB reduce safeguards or special conditions
imposed by the local IRS
A memorandum of Understanding (MOU) on this subject was first
executed by the Departments of Defense and Health, Education,-
and Welfare in 1964. It was revised in 1974 to state the
procedures that would be followed to ensure that the
requirements of the Federal Food, Drug, and Cosmetic Act and
its implementing regulations are fully met without
jeopardizing or impeding the requirements of national
security. Experience in operating under these MOUs from 1964
to 1987 indicates that the DOD and FDA have a record of
cooperation; that human subject concerns have been adequately
addressed in DoD-sponsored studies; that the DOD has been
able to carry out effectively its responsibilities for
national security without compromising the intent of the
above-cited statutes and regulations; and that certain
exemptions, relieving the DOD from the need to meet the
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 5 f:/Week-36/BX003203/MOU BETWEEN THE FOOD AND DRUG ADMINISTRATION AND DOD/moa on investigational use of drugs antibiotics:11089615090121
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = MOU BETWEEN THE FOOD AND DRUG ADMINISTRATION AND DOD
Folder Seq # = 133
Subject = MOA ON INVESTIGATIONAL USE OF DRUGS ANTIBIOTICS
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996